Data on common gastrointestinal side effects of different incretin-based therapies compared to placebo, pooled from other published systematic reviews and meta-analyses, highlights the lowest OR for nausea, vomiting, and diarrhoea with cagrilintide [Table 4].[22,24] Therefore, cagrilintide can be considered a promising therapeutic option for weight loss in obese individuals who may not tolerate GLP1RAs or have a lower tolerance for nausea and vomiting
In rare cases, severe dehydration associated with GLP-1 use has been linked to acute kidney injury
Diagnosis and Reason for Treatment Your healthcare provider must explain why the GLP-1 medication is being prescribed
At doses ranging from 40 to 200 mg taken twice daily, the highest weight reduction achieved was up to 11.7% compared to a 1.4% weight increase in the placebo group
By being gentle, focusing on hydration, and incorporating the right products, you can support your skins recovery and prevent future breakouts
The liver uses glutathione in what is known as Phase II detoxification